Clinical trial
Effects of Omega 3 in Hemodialysis Patients
NCT00431899 · Laboratoire Régional de Nutrition Humaine, Other · Completed
Key facts
| NCT number | NCT00431899 |
|---|---|
| Title | Effects of Omega 3 in Hemodialysis Patients |
| Official title | Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis |
| Lead sponsor | Laboratoire Régional de Nutrition Humaine, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hemodialysis, End Stage Renal Disease |
| Intervention type | Behavioral |
| Interventions | fish oil supplementation |
| Enrollment | 8 |
| Start date | May 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Feb 6, 2007 |
| Last update posted | Mar 3, 2016 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: